European Association for Cardiovascular Prevention & Rehabilitation (EACPR) A Registered Branch of the ESC

Similar documents
The HeartQol questionnaire. Reliability, validity and responsiveness?

Supplementary Appendix

Engagement in language assessment / Regions of Europe

Models of preventive care in clinical practice to achieve 25 by 25

WESTERN EUROPE PREVALENCE AND INCIDENCE OF PERIPHERAL ARTERY DISEASE AND CRITICAL LIMB ISCHEMIA 2017

PARALLELISM AND THE LEGITIMACY GAP 1. Appendix A. Country Information

Smokefree Policies in Europe: Are we there yet?

Atherosclerotic Cardiovascular Diseases: ischaemic heart disease and stroke

FOURIER STUDY GREYLOCK PRESS: CTS PRODUCT SAMPLE - FOURIER YES. Did the study achieve its main objective?

Adaptation and evaluation of early intervention for older people in Iranian.

WCPT COUNTRY PROFILE December 2017 HUNGARY

WCPT COUNTRY PROFILE December 2017 SWEDEN

WCPT COUNTRY PROFILE December 2017 SERBIA

508 the number of suicide deaths in deaths per 100,000 people was the suicide rate in Suicide deaths in 2013 by gender

Type 1 Diabetes Australian Research Impact Analysis

Grown-up congenital heart disease care throughout Europe

Department of Biological Standardisation OMCL Network & Healthcare (DBO)

The OECD Health Care Quality Indicators Project

the high CVD risk smoker

Rheumatoid Arthritis Disease Burden and Access to Treatment

Chapter 8: Patient-reported Health Instruments used for people with heart failure

Real Life, Real PD Survey

Palliative nursing care of children and young people across Europe

Professional International Study Management

Quality of Life Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA)

Design and Analysis of a Cancer Prevention Trial: Plans and Results. Matthew Somerville 09 November 2009

The health economic landscape of cancer in Europe

EASY-Care program in Iran. Dr Reza Fadayevatan, MD, MPH, PhD Head of Ageing Department, The University of Social welfare and Rehabilitation Sciences

Prof. Renata Cífková, MD, CSc.

European Community Pharmacy: a reference in Public Health

LEBANON. WCPT COUNTRY PROFILE December 2018

Emerging Risks Mapping of Activities in Member States. 67th Advisory Forum meeting, Utrecht, The Netherlands, 6 February 2018

DENMARK. WCPT COUNTRY PROFILE December 2018

High-Resource Perspective On Adolescent Transition and Research Priorities Ali Judd

Manuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal

Men & Health Work. Difference can make a difference Steve Boorman & Ian Banks RSPH Academy 2013

The Identification of Food Safety Priorities using the Delphi Technique

GSK Medicine: Study Number: Title: Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives:

GERMANY. WCPT COUNTRY PROFILE December 2018

Reza Fadayevatan Vida Alizad Ali Asgari

Overview of drug-induced deaths in Europe - What does the data tell us?

Cardiac Assessment Controls

TEDDY. Teddy Network of Excellence. Annagrazia ALTAVILLA. Ph.D. Sciences Ethics LL.M. Health Law. diterranée

European Collaboration on Dementia. Luxembourg, 13 December 2006

Burden and cost of alcohol, tobacco and illegal drugs globally and in Europe

Alcohol-related harm in Europe and the WHO policy response

BACKGROUND AND RATIONALE

MENTAL HEALTH CARE. OECD HCQI Expert meeting 17 th of May, Rie Fujisawa

Overall survival: 1 st line therapy

Access to treatment and disease burden

The first and only fully-automated, multiplexed solution for Measles, Mumps, Rubella and Varicella-zoster virus antibody testing

Secondary prevention and systems approaches: Lessons from EUROASPIRE and EUROACTION

2017 ICF GLOBAL CONSUMER AWARENESS STUDY

Psychosocial issues and Type D personality: Effects on rehabilitation Susanne S. Pedersen (PhD), Tilburg University, The Netherlands

Kenneth W. Mahaffey, MD and Keith AA Fox, MB ChB

HPV, Cancer and the Vaccination Programme

Pharmaceutical, Medical and Health-related Government and Regulatory bodies around the world.

Request for Letters of Intent. International Development of H5N1 Influenza Vaccines

31 countries (117 registries, 20 national) Increased coverage in countries with regional registries 50% European population Overall >20 million

PROGRESS ON HCQI RESEARCH AND DEVELOPMENT WORK

Bio-Rad Laboratories HEMOGLOBIN Testing Bio-Rad A1c. VARIANT II TURBO Link. Fully-Automated HbA 1c Testing

Where we stand in EFORT

The Risk of Alcohol in Europe. Bridging the Gap June 2004

ALCOHOL CONSUMPTION IN EUROPE; TRADITIONS, GENERATIONS, CULTURE AND POLICY

Feedback from the Member States questionnaire

Estimating Smoking Related Cause of Death: a Cohort Approach Based on Lung Cancer Mortality in six European Countries

Bio-Rad Laboratories. Cardiac Assessment Controls. Value Assigned for Clinical Laboratory and Point of Care Test Systems

Differences make a Difference

ESS Workshop, The Hague, March

Overview of European Consumption Databases

Infectious Disease Testing. ULTRA Product Line. Safety is not a Matter of Chance

Clinical Study Synopsis

FORUM FOR AEROSPACE NDT BOARDS

Cardiac Assessment Controls A critical element of reliable cardiac testing

Modelling diabetes Professor Alastair Gray Health Economics Research Centre University of Oxford

Background. Total: / 25 points. STS/EACTS Latin America Cardiovascular Surgery Conference 2018

BioPlex 2200 Infectious Disease Panels

Primary Endpoint The primary endpoint is overall survival, measured as the time in weeks from randomization to date of death due to any cause.

The influence of societal individualism on a century of tobacco use: modelling the prevalence of smoking Appendices A and B

Drinking guidelines used in the context of early identification and brief interventions in Europe: overview of RARHA survey results

Epidemiology and cost of chronic pain

OPTN/UNOS-Thoracic Organ Transplantation Committee: Proposed Modifications to Adult Heart Allocation

DECLARATION OF CONFLICT OF INTEREST. None

GERIATRIC TEACHING AND TRAINING IN EUROPE: Where are we? (part I)

A Global perspective on Heart Failure: What needs to change? Martin R Cowie London, United Kingdom

Injection Techniques Questionnaire (ITQ) WorldWide Results Needle Gauge

Abbott Vascular. PROTOCOL EXCEL Clinical Trial

Biology Report. Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis?

The Official Journal of the Kettil Bruun Society for Social and Epidemiological Research on Alcohol

Bio-Rad Laboratories HEMOGLOBIN Testing Bio-Rad A1c. VARIANT II TURBO Link System. Fully-Automated HbA 1c Testing

Results you can trust

CARDIOVASCULAR DISEASE AND DIABETES:

Multivariate relationships. Week 6 22 February, 2016 Prof. Andrew Eggers

Transcription:

Quality of life of cardiac patients in Europe: HeartQoL Project

Stefan Höfer The HeartQol Questionnaire: methodological and analytical approaches

Patients Treatment Is quality of life important in cardiovascular care? Survived Good condition %? HRQL Worse condition Death x% Mortality Death

Literature Consensus on HRQoL Instrument use? 10-year review of responsiveness of psychosocial instruments to cardiac rehabilitation interventions (1986-95) 32 interventions; 21 ES calculable; 16 QoL instruments (McGee, Hevey & Horgan, 1999) Cochrane review of exercise rehabilitation 11 RCTs; 18 QOL instruments = not possible to draw useful QOL-related conclusions about instruments or findings (Jolliffe et al, 2001)

HeartQoL Project A single valid HRQL instrument will optimize between-diagnosis, within- or across-treatment comparisons & increase efficiency of clinical service providers and researchers when assessing patient-reported outcomes Objective: Using established and validated condition-specific HRQL instruments, develope a valid and reliable core HRQL instrument for use in patients with myocardial infarction, angina pectoris, or heart failure which often exist or evolve sequentially in the same patient over time Oldridge N, et al. EJCPR, 2005

Criteria of HRQoL Instruments Conceptual and measurement model Reliability Validity Responsiveness Interpretability Alternative forms Respondent and administrative burden Objectivity Cultural and language adaptations Scientific Advisory Board, Quality of life Resaerch, 2002

Conceptual & measurement model QoL HRQoL... Physical Emotional Social...... Item 1 Item 2 Item 3 Item 1 Item 2 Item 3 Item 1 Item 2 Item 3

Reliability Is an instrument free from random error? Internal consistency the precision of a scale: i.e.: Cronbach s alpha Reproducibility stability over time: i.e.: Test-retest reliability

Validity Does an instrument measure what it purports to measure? Content-related: Evidence that the domain of an instrument is appropriate relative to its intended use Construct-related: Evidence that supports a proposed interpretation of scores based on theoretical implications associated with the constructs being measured Criterion-related: Evidence that shows the extent to which scores of the instrument are related to a criterion measure

Criteria of HRQoL Instruments Conceptual and measurement model Reliability Validity Responsiveness Interpretability Alternative forms Respondent and administrative burden Objectivity Cultural and language adaptations Scientific Advisory Board, Quality of life Resaerch, 2002

Responsiveness Is an instrument able to detect change over time? Evidence on the changes in scores of the instrument Longitudinal data that compare a group that is expected to change with a group that is expected to remain stable

Interpretability Are the numbers produced easily understood? Meaningful benchmarks to facilitate interpretation of the scores ( norms )... Pre post change... Clinical important difference

Valid disease-specific HRQL questionnaires used to develop a core IHD questionnaire MacNew MI Q 27 items 3 sub-scales: Physical Social Emotional Sub-scale scores Total Score Seattle Angina Q 19 items 5 sub-scales Physical limitation Angina stability Angina frequency Treatment satisfaction Disease perception Sub-scale scores Minnesota Living with Heart Failure Q 21 items 2 sub-scales Physical Emotional Sub-scale scores Total score

Valid disease-specific HRQL questionnaires used to develop a core IHD questionnaire MacNew MI Q 27 items 3 sub-scales: Physical Social Emotional Sub-scale scores Total Score Seattle Angina Q 19 items 5 sub-scales Physical limitation Angina stability Angina frequency Treatment satisfaction Disease perception Sub-scale scores Minnesota Living with Heart Failure Q 21 items 2 sub-scales Physical Emotional Sub-scale scores Total score 49 items

What we did Item reduction from 49 item to as few as possible: Clinical impact method Mokken scaling Item response theory Pre-testing the prototype instrument Decision about scoring method Determination of reliability Validation Goal reached: one common metric in heart disease in Europe and the world Primary analysis across the whole sample

Mokken Scaling Identifying items falling into a domain Ranking the items according to difficulty of endorsing Easiest item to endorse Most difficult item to endorse

Answer options

Eligibility

Eligibility

Eligibility

Eligibility

HeartQoL Project: International 21 countries 15 languages n= 6,249 Australia; Canada; USA SE: Portugal, Spain UK, Ireland NE: Denmark, Norway, Sweden WE: Austria, Belgium, France, Netherlands, Germany, Switzerland SE: Italy EE: Hungary, Poland, Russia, Ukraine

Sample mi primary: 37.3% angina primary: 33.1% heartfailure primary: 29.6% Age: 62.3±11.3 mi primary: 59.7±11.4 angina primary: 63.0±10.2 heartfailure primary: 64.9±11.5

HeartQoL patient profiles: International cohort summary HeartQoL Age / % male 62.3 / 75% BMI 27.4 Smoking 15.1% Diabetes 20.6% Treated for 90.1% Hypertension 55.4% Treated for 95.9% Hypercholesterolemia 59.6% Treated for 92.1% EuroAspire III 61.9 / 73% 28.0 18% 28% 35% 61% 89% 46% 88%

2000-2010 Data collection Item reduction Item analysis Item answering options... the HeartQoL